SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)

被引：1

作者：

Moran, Laura Ortega ^{[1
]}

Mateo, Francisco Jose Pelegrin ^{[2
]}

Balanya, Rut Porta ^{[3
]}

Revuelta, Jacobo Rogado ^{[4
]}

Martinez, Silverio Ros ^{[5
]}

Fombella, Jose Pablo Berros ^{[6
]}

Vazquez, Elena Maria Brozos ^{[7
]}

Caro, Natalia Luque ^{[8
]}

Langa, Jose Munoz ^{[9
]}

Fernandez, Mercedes Salgado ^{[10
]}

机构：

[1] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain

[2] Hosp St Creu i St Pau, Barcelona, Spain

[3] Hosp Universitari Dr Josep Trueta, ICO Girona, Hosp Universitari Dr, Girona, Spain

[4] Hosp Univ Infanta Leonor, Madrid, Spain

[5] Hosp Univ Virgen Arrixaca, Murcia, Spain

[6] Hosp Univ San Agustin, Aviles, Asturias, Spain

[7] Complexo Hosp Univ A Coruna, La Coruna, Spain

[8] Hosp Univ Jaen, Jaen, Spain

[9] Hosp Arnau Vilanova, Valencia, Spain

[10] Complexo Hosp Univ Ourense, Orense, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 11期

关键词：

Venous thromboembolism; Cancer; Anticoagulation; Guidelines; Low-molecular-weight heparins; Direct oral anticoagulants; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; DIRECT ORAL ANTICOAGULANTS; PLACEBO-CONTROLLED TRIAL; PHASE-III TRIAL; MEDICAL PATIENTS; EXTENDED THROMBOPROPHYLAXIS; AMBULATORY PATIENTS; PULMONARY-EMBOLISM; LAPAROSCOPIC SURGERY;

D O I：

10.1007/s12094-024-03605-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Spanish Society of Medical Oncology (SEOM) last published clinical guidelines on venous thromboembolism (VTE) and cancer in 2019, with a partial update in 2020. In this new update to the guidelines, SEOM seeks to incorporate recent evidence, based on a critical review of the literature, to provide practical current recommendations for the prophylactic and therapeutic management of VTE in patients with cancer. Special clinical situations whose management and/or choice of currently recommended therapeutic options (low-molecular-weight heparins [LMWHs] or direct-acting oral anticoagulants [DOACs]) is controversial are included.

引用

页码：2877 / 2901

页数：25

共 145 条

[21] Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis [J].

Bosch, Floris T. M. ;

Mulder, Frits, I ;

Kamphuisen, Pieter Willem ;

Middeldorp, Saskia ;

Bossuyt, Patrick M. ;

Buller, Harry R. ;

van Es, Nick .

BLOOD ADVANCES, 2020, 4 (20) :5215-5225

[22] Thrombosis, cancer, and COVID-19 [J].

Brito-Dellan, Norman ;

Tsoukalas, Nikolaos ;

Font, Carme .

SUPPORTIVE CARE IN CANCER, 2022, 30 (10) :8491-8500

[23] Form of presentation, natural history and course of postoperative venous thromboembolism in patients operated on for pelvic and abdominal cancer. Analysis of the RIETE registry [J].

Bustos Merlo, Ana Belen ;

Arcelus Martinez, Juan Ignacio ;

Turino Luque, Jesus Damian ;

Valero, Beatriz ;

Villalobos, Aurora ;

Angel Aibar, Miguel ;

Monreal Bosch, Manuel .

CIRUGIA ESPANOLA, 2017, 95 (06) :328-334

[24] Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series [J].

Campbell, Peter M. ;

Ippoliti, Cindy ;

Parmar, Sapna .

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (03) :220-225

[25] Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis [J].

Candeloro, Matteo ;

Valeriani, Emanuele ;

Monreal, Manuel ;

Ageno, Walter ;

Riva, Nicoletta ;

Lopez-Reyes, Raquel ;

Peris, Maria Luisa ;

Beyer Westendorf, Jan ;

Schulman, Sam ;

Rosa, Vladimir ;

Jose Lopez-Nunez, Juan ;

Garcia-Pagan, Juan-Carlos ;

Magaz, Marta ;

Senzolo, Marco ;

De Gottardi, Andrea ;

Di Nisio, Marcello .

BLOOD ADVANCES, 2022, 6 (15) :4516-4523

[26] Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study [J].

Carney, Brian J. ;

Wang, Tzu-Fei ;

Ren, Siyang ;

George, Gemlyn ;

Al Homssi, Amer ;

Gaddh, Manila ;

Connolly, Gregory C. ;

Shah, Vinay, I ;

Bogue, Thomas ;

Bartosic, Abigail ;

Neuberg, Donna ;

Kreuziger, Lisa Baumann ;

Zwicker, Jeffrey, I .

BLOOD ADVANCES, 2021, 5 (24) :5546-5553

[27] Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients [J].

Carrier, M. ;

Le Gal, G. ;

Cho, R. ;

Tierney, S. ;

Rodger, M. ;

Lee, A. Y. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (05) :760-765

[28] Apixaban to Prevent Venous Thromboembolism in Patients with Cancer [J].

Carrier, Marc ;

Abou-Nassar, Karim ;

Mallick, Ranjeeta ;

Tagalakis, Vicky ;

Shivakumar, Sudeep ;

Schattner, Ariah ;

Kuruvilla, Philip ;

Hill, Danny ;

Spadafora, Silvana ;

Marquis, Katerine ;

Trinkaus, Mateya ;

Tomiak, Anna ;

Lee, Agnes Y. Y. ;

Gross, Peter L. ;

Lazo-Langner, Alejandro ;

El-Maraghi, Robert ;

Goss, Glenwood ;

Le Gal, Gregoire ;

Stewart, David ;

Ramsay, Timothy ;

Rodger, Marc ;

Witham, Debra ;

Wells, Philip S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (08) :711-719

[29] Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer [J].

Carrier, Marc ;

Khorana, Alok A. ;

Moretto, Patricia ;

Le Gal, Gregoire ;

Karp, Rebecca ;

Zwicker, Jeffrey I. .

AMERICAN JOURNAL OF MEDICINE, 2014, 127 (01) :82-+

[30] Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer [J].

Cella, Chiara A. ;

Knoedler, Maren ;

Hall, Marcia ;

Arcopinto, Michele ;

Bagnardi, Vincenzo ;

Gervaso, Lorenzo ;

Pellicori, Stefania ;

Spada, Francesca ;

Zampino, Maria G. ;

Ravenda, Paola S. ;

Frassoni, Samuele ;

Passaro, Antonio ;

Milano, Monica ;

Laffi, Alice ;

Fazio, Nicola ;

Lordick, Florian .

JAMA NETWORK OPEN, 2023, 6 (02) :E230010

← 1 2 3 4 5 6 7 8 9 10 →